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Abstract The three-dimensional structure of the macrophage 
migration inhibitory factor (MIF) from human lymphocytes has 
been determined by X-ray crystallography at 2.1 A resolution. 
The structure was solved by a molecular replacement technique 
using the coordinates of rat MIF. The molecule forms a trimer 
structure similar to the rat MIF. However, unlike the rat MIF 
whose C-terminal tail (residues 104-114) is disordered in the 
crystal, human MIF has a deftite main-chain conformation up 
to the C-terminal end. These eleven residues create two more b 
strands and join to the inter-subunit bsheet, which contribute to 
forming a trhner structure. Thus, the trimer structure consists of 
three seven-stranded @-sheets surrounded by six a-helices. Each 
f&sheet is comprised of bstrands from each of the three 
monomers. This architecture is almost identical to S-carbox- 
ymethyl-2-hydroxymuconate isomerase (CHMI) and is related 
to the E. coli signal transducing protein Pn. 
k :y words: Cytokine; Isomerase; Macrophage; X-ray crystal 
sl ,mucture 
1. Introduction 
The macrophage migration inhibitory factor (MIF) was 
originally identified as a cytokine, derived from T-lympho- 
c! tes to prevent the mobilization of guinea-pig macrophages 
ir. vitro [1,2]. Further investigation revealed that MIF is se- 
crcted from the pituitary and macrophages by lipopolysac- 
cl aride (LPS) stimulation, and counter-regulates the immuno- 
s~.ppresive effects of glucocorticoid to act as a critical 
c( mponent of the immunity system [3,4]. Many other proper- 
tit s of MIF, besides its property as a immunoregulatory pro- 
te n have also been found. MIF exists not only in immune 
ccIls, but also in other cell types such as chicken differentiat- 
in: cells of the eye lens, mouse 3T3 fibroblastic cells and rat 
Ii\ er cells [5-71. A recent report showed that MIF from the 
bl $vine lens has enzyme activity to catalyze the tautomeriza- 
tit m of 2-carboxy-2,3-dihydroindole-5,6-quinone (D-dopa- 
cl rome) to 5,6-dihidroxyindole-2-carboxylic acid (DHICA) 
[8 . Moreover, the three-dimensional structure of MIF from 
tb,? rat liver has apparent structural similarities with an iso- 
m :rase [9]. 
Human MIF is composed of 114 amino acid residues 
(h [W = 12 300) and has 90% amino acid sequence homology 
tc the rat MIF. Although there have been many studies of 
M IF, little is known about its functions and reaction mechan- 
isn in the immunity system. We report here on the crystal 
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structure of MIF from human lymphocytes determined at 2.1 
a resolution by the method of molecular replacement. 
2. Material and methods 
Crystals of human MIF were grown by hanging-drop vapor diffu- 
sion at 18°C with 2.1 M ammonium sulfate buffered with 100 mM 
Tris-HCI (pH 8.5). The details of overexpression, purification and 
crystallization have been described previously [lo]. Only the orthor- 
hombic crystal form was used in the present study (space group 
P212.121 with unit cell parameters a = 68.4, b= 68.8, c = 86.8 A, three 
subunits in an asymmetric unit). X-ray intensity data were recorded 
on an imaging-plate system, DIP-2000~ (MAC Science, Japan) using 
Cu Ka radiation. Rotation and translation searches were calculated 
by XPLOR [l 1] using the coordinates of the rat MIF trimer produced 
by the crystallographic three-fold axis [9]. This model includes resi- 
dues 1 to 103. After the first cycle of simulated annealing refinement, 
the (ZFo-Fc)-map was calculated, which showed a clear electron den- 
sity including the C-terminal region (residues 104 to 114), where no 
density was observed for the rat MIF. At this stage, the electron 
density map was averaged using the local three-fold axis. The result- 
ing map was sufficiently improved. The model was rebuilt and was 
subjected to simulated annealing, energy minimization and B-factor 
refinement in XPLOR. The final-R-fact& is 22.4%, and free R-factor 
is 27.1% for all reflections in the resolution range of 8.c2.1 A. This 
model contained 125 water molecules with temperature factor values 
B < 50 AZ. All main-chain dihedral angles fall within allowed (91.7%) 
or additional allowed (8.3%) regions [12] of the Ramachandran plot. 
The root mean square deviations from ideal bond lengths and angles 
were 0.011 A and 1.44”, respectively. 
3. Results 
Human MIF forms a trimer structure similar to the rat 
MIF. However, unlike the rat MIF whose C-terminal tail 
(residues 104114) is disordered in the crystal, human MIF 
has a definite main-chain conformation up to the C-terminal 
end. Fig. 1 shows a MOLSCRIPT [13] schematic diagram for 
the human MIF monomer. The secondary-structure assign- 
ment is given in Fig. 2. The assignment of the secondary 
structure is almost consistent with the rat MIF C-terminal 
eleven residues, which were disordered in the crystal of the 
rat MIF, create two more P-strands and join to the inter- 
subunit P-sheet, thus contributing to forming a trimer struc- 
ture, which we describe later in more detail. 
The central part of the monomer structure of human MIF 
consists of a mixed four-stranded P-sheet with two antiparallel 
helices, which is flanked on one side by one P-strand (p3; 
residues 46-50) and on the opposite side by two P-strands 
(p6; residues 105-108, and fi7; 111-113). There is a pseudo 
two-fold axis running perpendicular to the P-sheet in the 
monomer (Fig. 1). The three monomers are linked together 
by the hydrogen bonds and create a trimer. Each P-sheet in the 
trimer is comprised of P-strands from each of the three mono- 
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Fig. 1. MOLSCRIPT [13] schematic diagram for the 2.1 A human 
MIF monomer. Unlike the rat MIF, whose C-terminal eleven resi- 
dues are disordered, human MIF has a definite main-chain confor- 
mation up to the C-terminal end. These eleven residues create two 
extra P-strands (strands 6 and 7). The molecule is viewed from a 
pseudo two-fold rotation axis. 
mers. The relationship of secondary structural elements within 
a trimer is shown in the topological diagram (Fig. 3). With 
extra B-strands (strands 6 and 7) the molecule forms a more 
symmetrical trimeric cage-like structure. Thus, the trimer 
structure consists of three seven-stranded B-sheets surrounded 
by six a-helices (Fig. 4 top). We call this structure a trimeric 
B-cage. The overall shape of the MIF trimeric B-cage is cy- 
lind$cal with approximate dimensions of 54 A diameter and 
38 A axial length. There is a channel at the center around the 
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three-fold axis of the trimer. The size of the channel varies 
from 7 A to 15 A, and is large enough for water molecules to 
pass through. Three subunits are arranged in such a way that 
a non-crystallographic three-fold axis runs through the center 
and the pseudo two-fold symmetry axis in a monomer verti- 
cally intersects the three-fold axis. Therefore, human MIF 
trimer exhibits the approximate point group, Ds(32) (Fig. 4 
bottom). 
In previous studies, MIF has been described as a monomer 
or dimer [14,15]. However, the fact that the same trimer struc- 
ture was found in different crystals of proteins from different 
species strongly suggests that the trimer is the physiologically 
important structure. 
4. Discussion 
The structure of the rat MIF has been solved recently, 
revealing an unexpected similarity to the enzyme Scarboxy- 
methyl-2-hydroxymuconate isomerase (CHMI) from E. coli. 
CHMI catalyzes the isomerization of 5-carboxymethyl-2-hy- 
droxymuconate (CHM) to 5-carboxymethyl-2-oxo-3-hexene- 
1,6-dioate (COHED) [16], and has very low sequence homol- 
ogy to the rat MIF (20 out of 126 residues are identical). Both 
structures consist of three B-sheets surrounded by six a-helices 
and their topologies in trimer formation are almost identical. 
The largest differences between these two molecules are in the 
C-terminal region; C-terminal eleven residues of the rat MIF 
are disordered in the crystal while they form a P-strand in the 
CHMI. 
Human MIF is more similar to the CHMI than the rat 
MIF in the overall folding topology of the monomer and 
trimer. It has two extra B-strands in the region of the C-term- 
inal eleven residues, which were disordered in the rat MIF. In 
each monomer of human MIF, strand 6 (residues 105-108) 
1 10 20 
human Pro Met Phe Ile Val Asn Thr Asn Val Pro Arg Ala Ser Val Pro As Gly Phe Leu Ser Glu Leu Thr Gln Gln 
rat 
30 40 50 
human Leu Ala Gln Ala Thr Gly Lys Pro Pro Gln Tyr Ile Ala Val His Val Val Pro Asp Gln Leu Met 
rat Leu Ala Gln Ala Thr Gly Lys Pro Ala Gln Tyr Ile Ala Val His Val Val Pro Asp Gln Leu Met 
60 70 
Pro Cys Ala Leu Cys Ser Leu Ais Ser Ile Gly Lys Ile Gly Gly Ala Gin Am Arg 
Pro Cys Ala Leu Cys Ser Leu His Ser Ile Gly Lys Ile Gly Gly Ala Gln Am Arg 
SO 90 100 
human Ser Lys Leu Leu Cys Gly Leu Leu Ala Glu Ile Ser Pro Asp Arg Val Tyr Ile Am Tyr Tyr Asp 
rat Ser Lys Leu Leu Cys Gly Leu Leu Ser Asp Ile Ser Pro Asp Arg Val Tyr Ile Am Tyr Tyr Asp 
human Met Am Ala Ala Am Val Gly Trp Am Am Ser Thr Phe Ala 
rat Met Am Ala Ala Am Val Gly Trp Am Gly Ser Thr Phe Ala 
Fig. 2. Sequence alignment of human and rat MIF and the secondary structure assignment for human MIF. The secondary structural elements 
have been assigned by the inspection of hydrogen bonding and torsion angles. 
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which is missing in the rat MIF, contributes to the hydrogen 
bonds with its neighboring monomer in the trimer in a similar 
way to CHMI. These extra P-strands make the trimer packing 
more symmetrical and firm. There is, however, another differ- 
ence between human MIF and CHMI in the secondary struc- 
tur-e of the C-terminal region. The C-terminal three residues 
(1’ 1-113) of human MIF which turn back at the p-turn 
(n sidues 108-l 11) make a short seventh P-strand. In contrast, 
th : corresponding region of CHMI is comprised of a 310 helix 
(n sidues 121-125) which protrudes into the solvent. 
Inspection of amino acid sequences in the C-terminal region 
re realed only one amino acid difference between the rat and 
ht man MlF (Fig. 2). Asn at position 110 is replaced by Gly in 
th : rat MIF. The other different residues do not seem to 
significantly affect the structure of the C-terminal region. 
Tl e existence of a small amino acid in this region may endow 
a jeptide chain with a flexible nature, resulting in the disor- 
de’-ed structure of the rat MIF. A second possible explanation 
is .hat the disordered C-terminal tail of the rat MIF is simply 
dt e to crystal packing. The three-fold axis of the human MIF 
tr ner is not a crystallographic one. On the other hand, the 
th .ee-fold axis of the rat MIF trimer is consistent with a 
cr stallographic one. An exact symmetry may cause the dis- 
or lered structure in the rat MIF. Whatever the reason is, it is 
in portant to note that the C-terminal region does not appear 
to significantly affect the construction of the trimer structure, 
ar d it has some kind of flexibility. 
4nother protein structure which shows some similarities 
w~.h MIF is the E. coli signal transducing protein Prr 
[ 1 ,181. Pn plays a critical role in bacterial nitrogen regulation 
by controlling the level and activity of glutamine synthetase. 
Tl is protein also forms a trimer which is comprised of three 
p- ,heets surrounded by six a-helices. However, the monomer 
st! ucture of Pir consists of a central region containing four- 
st anded antiparallel P-sheet and two antiparallel helices, 
Fit. 3. Topological diagram illustrating the secondary structure ele- 
ments of human MIF. P-strands are represented by arrows and CL- 
helices by circles. The C-terminal eleven residues, which are disor- 
dered in the rat MIF [9], form two more P-strands and join to the 
P-sheet. 
Fig. 4. (top) Trimeric P-cage structure of human MIF viewed from 
a three-fold axis. (bottom) Schematic representation of human MIF 
trimer showing pseudo Ds(32) symmetry. 
which are connected by intervening loops. Although the fold- 
ing of the Pn monomer is distinct from MIF and CHMI, the 
way of interactions between each monomer is identical among 
these molecules. There have been no reports that Pir is related 
to the immune system or isomerase activities. These remark- 
able structural similarities of two distinct proteins with no 
sequence homology suggests the importance of P-cage pack- 
ing, which is characterized by the three central P-sheets and 
high symmetry with the approximate point group Ds. 
The ideal Ds symmetry can be formed only by hexameric 
molecules. This is the case for hexameric 4-oxalocrotonate 
tautomerase (4-OT). 4-OT catalyzes an analogous reaction 
to CHMI, and its three dimers, each of which is remarkably 
similar to the human MIF and CHMI monomer, are arranged 
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Fig. 5. Proposed catalytic pocket of human MIF in the region close 
to-the N-terminal Pro residue. It is surrounded by aromatic resi- 
dues. Unlike the C-terminal tail of CHMI. which forms a 310 helix 
and protrudes in the opposite direction of the active site, -the C- 
terminal P-strand of human MIF participates in a B-sheet and is lo- 
cated near the pocket (especially the side chain of Phe 113). 
around the three-fold axis to form a hexamer [19]. The amino 
acid sequence does not show any similarity with CHMI. 
It is proposed that the catalytic base of CHMI is the N- 
terminal Pro residue which is located in the negatively charged 
pocket on the molecular surface [19]. On the other hand, 
although MIF was recently reported to catalyze the tautomer- 
ization of 2-carboxy-2,3-dihydroindole-5,6-quinone (o-dopa- 
chrome) to 5,6-dihidroxyindole-2-carboxylic acid (DHICA) 
[8], nothing is known about its active site. MIF does have a 
pocket in a similar region close to the N-terminal Pro residue. 
However, unlike CHMI, it is surrounded by aromatic residues 
[9]. The C-terminal 31s helix of CHMI protrudes in the oppo- 
site direction to the active site, whereas in the human MIF, 
the C-terminal P-strand participates in a P-sheet and is located 
near the pocket (especially the side chain of Phe 113) (Fig. 5). 
There is no evidence that this pocket is the active site for 
tautomeration. However, in view of the structural similarity 
of the two proteins, it would be rational to speculate that the 
catalytic sites of the two proteins are in the same region. The 
flexible nature of the C-terminal tail may effectively be related 
to the enzymatic activities. 
In conclusion, we observed the trimeric P-cage structure in 
human MIF. A comparison with other P-cage structures sug- 
gests that the C-terminal tail has some kind of flexibility. The 
location of the tail is close to the proposed active site and may 
be related to the enzymatic activities. 
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